Vitiligo: an update on current pharmacotherapy and future directions.

Vitiligo: an update on current pharmacotherapy and future directions.

Item
http://www.wikidata.org/entity/Q38029792
The effect of pseudocatalase/superoxide dismutase in the treatment of vitiligo: A pilot studyTriple combination treatment with fractional CO2 laser plus topical betamethasone solution and narrowband ultraviolet B for refractory vitiligo: a prospective, randomized half-body, comparative study.Narrow band-ultraviolet B versus clobetasol propionate foam in the treatment of vitiligo: a retrospective study.Mutant HSP70 reverses autoimmune depigmentation in vitiligo.Novel approaches to vitiligo treatment via modulation of mTOR and NF-κB pathways in human skin melanocytes.Lack of association between the 389C>T polymorphism (rs769217) in the catalase (CAT) gene and the risk of vitiligo: an update by meta-analysis.Oxidative stress and immune system in vitiligo and thyroid diseases.An Innovative Therapeutic Protocol for Vitiligo: Experience with the Use of Fraxel Herbium Laser, Topical Latanoprost and Successive Irradiation with UVA - 1 Laser.
P2860

Vitiligo: an update on current pharmacotherapy and future directions.

Item
http://www.wikidata.org/entity/Q38029792
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vitiligo: an update on current pharmacotherapy and future directions.
@en
type
label
Vitiligo: an update on current pharmacotherapy and future directions.
@en
prefLabel
Vitiligo: an update on current pharmacotherapy and future directions.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Vitiligo: an update on current pharmacotherapy and future directions.
@en
P2093
P2860
P304
P31
P356
10.1517/14656566.2012.712113
P407
P433
P478
P50
P577
P698
P921